Archive · 5 Jun 2025
Wockhardt MD: India-Made Drugs Prescribed Frequently in UK
Imagine doctors in the UK giving out prescriptions.
A big company's boss says that one out of every three of those prescriptions is for medicine made in India.
He's proud because his company helped make COVID-19 vaccines for the UK.
India is getting better at making these kinds of drugs.
The company is also working on new medicines and wants to sell them in places like the US.
The boss also wants India to explain to the world how it protects these new drug ideas and how they try to balance these protections with the need to provide good drugs to people.
The company is also working on deals to grow and hopes the government makes it easier for businesses to succeed.
Wockhardt's MD says one in three NHS prescriptions in the UK recommend India-made drugs.
India has made rapid strides in generic drugs.
Wockhardt supplied 60% of the UK's COVID-19 vaccines.
A potential antibiotic is in rapid progress.
Company is in discussions for potential collaborations.
- Who
- Ravi Limaye, Managing Director of Wockhardt.
- What
- One in three NHS prescriptions in the UK recommend drugs made in India.
- When
- Information was shared recently.
- Where
- United Kingdom (UK)
- Why
- To highlight the growing influence and potential of Indian pharmaceuticals.
IPR and Public Good
Indian Pharmaceutical Industry
IPR and Market Expansion
IPR and Public Good
India balances IPR with public good.
Indian Pharmaceutical Industry
India has made significant strides in generic drugs and non-patent drugs, offering potential for expansion.
- Company Executive
- Ravi Limaye (Wockhardt's MD)
- NHS Prescriptions
- 1 in 3 recommend India-made drugs
- Vaccine Sourcing
- 60% of UK's COVID-19 vaccines from Wockhardt
- Future Market
- Potential for expansion in Europe, US
- Business Strategy
- Advanced discussions for collaborations